Low diagnostic yield of GBA1 testing in incidentally detected thrombocytopenia or splenomegaly: a general population-based genetic study

Background Gaucher disease type 1 (GD1) is a rare, treatable lysosomal storage disorder caused by biallelic pathogenic variants in GBA1 . Thrombocytopenia and splenomegaly are common manifestations of GD1, but both are non-specific and frequent in clinical practice. The diagnostic yield of GBA1 testing in individuals with incidentally detected thrombocytopenia or splenomegaly in the general population is uncertain. Methods We evaluated the prevalence of pathogenic GBA1 variants among individuals from the Copenhagen General Population Study with hematological or radiological findings suggestive of GD1. Among 107,983 individuals with available blood counts, 79,310 remained eligible after exclusion of individuals with neutropenia, leukocytosis, increased hemoglobin, isolated anemia (without thrombocytopenia), thrombocytosis, or prior hematological disease. Of these, 231 individuals had isolated moderate-to-severe thrombocytopenia or thrombocytopenia combined with anemia and underwent amplicon-based next-generation sequencing of the GBA1 exonic sequence. Among 8,226 individuals who had abdominal CT scans including spleen volume measurements, 82 had splenomegaly, defined as spleen volume > 99th percentile (> 433 mL), and these underwent targeted Sanger sequencing for common pathogenic GBA1 variants. No individuals overlapped between the groups sequenced due to thrombocytopenia ( n = 231) and splenomegaly ( n = 82). Results No pathogenic GBA1 variants were identified among the 231 individuals in the thrombocytopenia group. Seven individuals carried likely benign variants, including p.Thr408Met in three, p.Glu365Lys in three, and the intronic variant c.307+28​G > ​T in one. Among the 82 individuals with splenomegaly, two heterozygous carriers of pathogenic GBA1 variants were identified: one with p.Asn409Ser and one with c.1265_1319del. No individual in either group carried a genotype consistent with GD1. Additional assessment of potential GBA1 / GBA1 LP misalignment in the next-generation sequencing data did not identify missed carriers of p.Leu483Pro or c.1265_1319del. Conclusions In this population-based study of individuals with incidentally detected thrombocytopenia or splenomegaly, we detected no genotypes consistent with GD1. These findings suggest that undiagnosed GD1 is unlikely to be a common cause of splenomegaly, isolated moderate-to-severe thrombocytopenia, or thrombocytopenia combined with anemia in similarly selected, predominantly middle-aged and older adults from the general population. Routine GBA1 screening based solely on these findings is therefore likely to have low diagnostic yield, although targeted testing remains appropriate when additional clinical features raise suspicion of GD1.

Authors

Institutions

Publication Details

Journal
Orphanet Journal of Rare Diseases
Published
2026-11-21
DOI
https://doi.org/10.1186/s13023-026-04726-3
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Low diagnostic yield of GBA1 testing in incidentally detected thrombocytopenia or splenomegaly: a general population-based genetic study

Anne Rudbeck Juhl, Per Ejlstrup Sigvardsen, Jesper Petersen, Michael Huy Cuong Pham et al.
2 links
Orphanet Journal of Rare Diseases
Lysosomal Storage Disorders Research
article

Low diagnostic yield of GBA1 testing in incidentally detected thrombocytopenia or splenomegaly: a general population-based genetic study

Anne Rudbeck Juhl, Per Ejlstrup Sigvardsen, Jesper Petersen, Michael Huy Cuong Pham, Jens Helby, Andreas Birkedal Glenthøj, Morten Dunø, Thomas Skårup Kristensen, Selma Kofoed Bendtsen, Andreas Fuchs Larsen, Stig E. Bojesen, Jørgen Kühl, Klaus Fuglsang Kofoed, Børge Grønne Nordestgaard
article en

Abstract

Background Gaucher disease type 1 (GD1) is a rare, treatable lysosomal storage disorder caused by biallelic pathogenic variants in GBA1 . Thrombocytopenia and splenomegaly are common manifestations of GD1, but both are non-specific and frequent in clinical practice. The diagnostic yield of GBA1 testing in individuals with incidentally detected thrombocytopenia or splenomegaly in the general population is uncertain. Methods We evaluated the prevalence of pathogenic GBA1 variants among individuals from the Copenhagen General Population Study with hematological or radiological findings suggestive of GD1. Among 107,983 individuals with available blood counts, 79,310 remained eligible after exclusion of individuals with neutropenia, leukocytosis, increased hemoglobin, isolated anemia (without thrombocytopenia), thrombocytosis, or prior hematological disease. Of these, 231 individuals had isolated moderate-to-severe thrombocytopenia or thrombocytopenia combined with anemia and underwent amplicon-based next-generation sequencing of the GBA1 exonic sequence. Among 8,226 individuals who had abdominal CT scans including spleen volume measurements, 82 had splenomegaly, defined as spleen volume > 99th percentile (> 433 mL), and these underwent targeted Sanger sequencing for common pathogenic GBA1 variants. No individuals overlapped between the groups sequenced due to thrombocytopenia ( n = 231) and splenomegaly ( n = 82). Results No pathogenic GBA1 variants were identified among the 231 individuals in the thrombocytopenia group. Seven individuals carried likely benign variants, including p.Thr408Met in three, p.Glu365Lys in three, and the intronic variant c.307+28​G > ​T in one. Among the 82 individuals with splenomegaly, two heterozygous carriers of pathogenic GBA1 variants were identified: one with p.Asn409Ser and one with c.1265_1319del. No individual in either group carried a genotype consistent with GD1. Additional assessment of potential GBA1 / GBA1 LP misalignment in the next-generation sequencing data did not identify missed carriers of p.Leu483Pro or c.1265_1319del. Conclusions In this population-based study of individuals with incidentally detected thrombocytopenia or splenomegaly, we detected no genotypes consistent with GD1. These findings suggest that undiagnosed GD1 is unlikely to be a common cause of splenomegaly, isolated moderate-to-severe thrombocytopenia, or thrombocytopenia combined with anemia in similarly selected, predominantly middle-aged and older adults from the general population. Routine GBA1 screening based solely on these findings is therefore likely to have low diagnostic yield, although targeted testing remains appropriate when additional clinical features raise suspicion of GD1.

Orphanet Journal of Rare Diseases
University of Copenhagen (DK), Amager Hospital (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK)
Sanofi, Gentofte Hospital, Rigshospitalet
Good health and well-being
Lysosomal Storage Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon